Fortress Biotech (FBIO)
(Real Time Quote from BATS)
$3.58 USD
+0.02 (0.56%)
Updated Sep 19, 2025 03:32 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
FBIO 3.58 +0.02(0.56%)
Will FBIO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for FBIO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for FBIO
Fortress Biotech (FBIO) Reports Q2 Loss, Beats Revenue Estimates
Repare Therapeutics Inc. (RPTX) Reports Q2 Loss, Misses Revenue Estimates
FBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Coherus Oncology (CHRS) Reports Q2 Loss, Beats Revenue Estimates
Why Fast-paced Mover Fortress Biotech (FBIO) Is a Great Choice for Value Investors
Ultragenyx (RARE) Surges 5.1%: Is This an Indication of Further Gains?
Other News for FBIO
FBIO's price rises by 3.49% on September 18, though its technical setup remains stable.
NR7 appears for FBIO after 0.29% move
FBIO's price falls by 3.38% on September 16, though its technical setup remains stable.
Is FBIO poised for gains? Slingshot Bullish shows up after crashing 8.74%
Largest borrow rate increases among liquid names